Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

PCOS is a common hormonal disorder in women linked to several health risks and can be managed through various treatments.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Genetic risk factors for Polycystic Ovary Syndrome can affect men too, not just women.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Skin hormone levels change significantly after menopause.

Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

Understanding hair follicle changes and hormones is key to diagnosing and treating hair loss.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Women with androgenetic alopecia may have higher blood pressure levels.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Androgenetic alopecia affects many people, impacting quality of life, and treatment focuses on reversing hair follicle miniaturization.

Androgens significantly affect female hair loss, and hormonal treatments may help.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Late onset of first period and irregular development of sexual traits in teenage girls can lead to poorer reproductive health.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Finasteride helps induce ovulation in nonresponder PCOS women.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

γ‐Oryzanol ointment increases sebaceous gland activity and sebum production.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.